Guest guest Posted September 15, 2005 Report Share Posted September 15, 2005 Aug. 10, 2005: Pfizer applies for FDA approval of cancer drug Aug 11, 2005 Pfizer is seeking FDA approval for Sutent to treat a rare stomach cancer called GIST (for gastrointestinal stromal tumors) and metastatic renal cell carcinoma among patients whose tumors do not respond to, or do not tolerate, standard treatment options. In a study with Sutent, the drug proved effective in stanching growth of GIST in 385 patients who had developed resistance to the blockbuster cancer drug Gleevec from Novartis. (Houston Chronicle -- Health) Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.